Atlas FDA

SurVeil Drug-Coated Balloon

FDA premarket approval P210025 · decided 2023-06-16

Approval details

PMA number
P210025
Trade name
SurVeil Drug-Coated Balloon
Generic name
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
Applicant
Surmodics,Inc.
Date received
2021-06-21
Decision date
2023-06-16
Days to decision
725 days
Decision code
APPR
Product code
ONU
Advisory committee
Cardiovascular
Expedited review
No
Location
Eden Prairie, MN
Statement
Approval for the SurVeil DCB. The device is indicated for use for percutaneous transluminal angioplasty, after appropriate vessel preparation, of de novo or restenotic lesions (</= 180 mm in length) in femoral and popliteal arteries having reference vessel diameters of 4 mm to 7 mm.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Pounce(TM) Sheath (K252227)Surmodics,Inc.2025-09-24
Pounce XL Thrombectomy System (PTS-1011-7F135) (K241362)Surmodics,Inc.2024-09-11
Microcatheter (K232647)Surmodics,Inc.2023-09-29
Pounce™ Sheath (K231828)Surmodics,Inc.2023-09-07
Pounce™ Thrombectomy System (K231022)Surmodics,Inc.2023-06-12
Sublime Microcatheter (K221886)Surmodics,Inc.2022-10-14
Pounce Thrombectomy System (K220501)Surmodics,Inc.2022-03-23
Pounce Thrombectomy System (K211492)Surmodics,Inc.2021-07-30